Attached files

file filename
EX-99.1 - Symmetry Medical Inc.v207813_ex99-1.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 

 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): January 10, 2011
 
SYMMETRY MEDICAL INC.
(Exact name of Registrant as specified in its charter)
 

 
Delaware
 
001-32374
 
35-1996126
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 
3724 N State Road 15, Warsaw, Indiana 46582
(Address of Principal executive offices, including Zip Code)
 
(574) 268-2252
(Registrant’s telephone number, including area code)
 
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 
 
Item 8.01.  Other Events

On January 10, 2011, Symmetry Medical, Inc. issued a press release entitled “Symmetry Medical Board of Directors Appoints Thomas J. Sullivan President and Chief Executive Officer,” in which it announced the appointment of Thomas J. Sullivan as President and Chief Executive Officer effective January 17, 2011, as well as the reassignment of current President and CEO, Brian Moore, to the position of President, Business Development effective that date.

A copy of this press release is being furnished as Exhibit 99.1.
 
Item 9.01.  Financial Statements and Exhibits
 
(d) 
Exhibits
 
99.1
“Symmetry Medical Board of Directors Appoints Thomas J. Sullivan President and Chief Executive Officer,” Press Release issued by Symmetry Medical, Inc. dated January 10, 2011.
________________

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
Symmetry Medical Inc.
   
 
/s/ Fred L. Hite
Date: January 10, 2011
Name:  Fred L. Hite
 
Title:    Chief Financial Officer
 

EXHIBIT INDEX
  
Exhibit
No.
  
Description
     
99.1
 
“Symmetry Medical Board of Directors Appoints Thomas J. Sullivan President and Chief Executive Officer,” Press Release issued by Symmetry Medical, Inc. dated January 10, 2011.